Hydroxylated inhibitors of hiv reverse transcriptase

C - Chemistry – Metallurgy – 12 – P

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

C12P 17/16 (2006.01) A61K 31/435 (2006.01) A61K 31/495 (2006.01) C07D 213/74 (2006.01) C07D 401/02 (2006.01) C07D 401/12 (2006.01) C07D 405/02 (2006.01) C07D 409/02 (2006.01) C07D 413/02 (2006.01) C07D 413/12 (2006.01) C07D 417/02 (2006.01) C07D 498/04 (2006.01) C12P 17/12 (2006.01)

Patent

CA 2053512

155/RDM80 156/RDM81 18212Y TITLE OF THE INVENTION HYDROXYLATED INHIBITORS OF HIV REVERSE TRANSCRIPTASE ABSTRACT OF THE DISCLOSURE Novel biotransformed or synthetic hydroxy pyridinones inhibit HIV reverse transcriptase, and are useful in the prevention or treatment of infection by HIV and the treatment of AIDS, either as compounds, pharmaceutically acceptable salts (where appropriate), pharmaceutical composition ingredients, whether or not in combination with other antivirals, anti-infectives, immunomodulators, antibiotics or vaccines. Methods of treating AIDS and methods of preventing or treating infection by HIV are also described.

LandOfFree

Say what you really think

Search LandOfFree.com for Canadian inventors and patents. Rate them and share your experience with other people.

Rating

Hydroxylated inhibitors of hiv reverse transcriptase does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with Hydroxylated inhibitors of hiv reverse transcriptase, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Hydroxylated inhibitors of hiv reverse transcriptase will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFCA-PAI-O-1483553

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.